Articles

Testing for COVID-19

Avacta and Adeptrix collaborate on new antigen test to identify coronavirus
Written byJennifer Clifford
| 3 min read

CAMBRIDGE, U.K. & BEVERLY, Mass.—Avacta recently announced a collaboration with Adeptrix through which the companies will work to develop a high-throughput COVID-19 antigen test using Adeptrix’s proprietary bead-assisted mass spectrometry (BAMS) platform, reportedly providing clinicians with a significant expansion of the available testing capacity for COVID-19 infection in hospitals using samples from saliva, nasopharyngeal swabs or serum.

“We are delighted to have established this partnership with Adeptrix in our push to develop Affimer -based COVID-19 antigen tests,” said Dr. Alastair Smith, CEO of Avacta Group. “Jeff [Dr. Jeffrey C. Silva] and his team are world-renowned in the mass spectrometry field, and the BAMS diagnostic platform is highly sensitive and specific, giving us great confidence that a high-performance COVID-19 antigen test can be developed and launched commercially very quickly.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.